Meta-analysis of the effect of the C-allele of <i>TMEM154</i>-rs6813195 on insulinogenic index in 6,486 individuals from the Inter99 study (n = 5,181), Health 2008 study (n = 592),... by Marie Neergaard Harder (232759)

Relevant information on key targets and biomarkers docking. by Ying Shen (48310)

Cu ions inhibit Prs. by Javiera Norambuena (137228)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”

Copper detoxification contributes to <i>S</i>. <i>aureus</i> pathogenesis. by Javiera Norambuena (137228)

Time-dependent effects of pre-exposure to rotenone. by Joseph A. Covi (3131166)

T2D case-control analyses of up to 5,777 patients from Inter99 (n = 320), Health 2006 (n = 166), Health 2008 (n = 18), Steno Diabetes Center (n = 1,424), ADDITION (n = 1,870) and V... by Marie Neergaard Harder (232759)

Genetically altering the demand for PRPP modulates the sensitivity to Cu(II). by Javiera Norambuena (137228)

5-year persistence of innate immune responses to VZV-gE after RZV administration. Data were derived from 14 RZV recipients who received 2 doses of vaccine at Days 0 and 60. Demogra... by Michael J. Johnson (5818168)

Growth with Cu(II) alters pentose phosphate pathway function. by Javiera Norambuena (137228)

EBNA3C down-regulated RASSF1A mRNA expression by enhancing RASSF1A promoter methylation. by Shengwei Zhang (321384)

“…<p>(A-D) RASSF1A mRNA expression was decreased in A-B) EBV positive cell lines and C-D) BJAB7, BJAB10, LCL1, and LCL2 cells. 5 million B-cells were collected and total RNA extracted via Trizol reagent. cDNAs were generated by reverse transcriptase kit and RASSF1A mRNA expression level was detected by real-time PCR. …”

eGFR trajectories by type of physical activity. by Ronit Calderon-Margalit (584756)

“…</p><p>Results</p><p>During 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m² per year. …”

Level of stress before March 2020 and after (Willcox test). by Łukasz Kołodziej (5329022)

Analysis of MDS results. by Ying Shen (48310)

Growth with Cu(II) alters metabolite pools. by Javiera Norambuena (137228)

Concentrations of ¹³C carbon atoms in select metabolites after growth in TSB medium containing ¹³C glucose. by Javiera Norambuena (137228)

CD31 immunohistochemical staining of portal vein in each group of rats. by Zixiang Wang (7548716)